These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28484970)

  • 1. Hallucinogens in Drug Discrimination.
    Baker LE
    Curr Top Behav Neurosci; 2018; 36():201-219. PubMed ID: 28484970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines.
    Winter JC
    Psychopharmacology (Berl); 2009 Apr; 203(2):251-63. PubMed ID: 18979087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic phenethylamine hallucinogen treatment alters behavioral sensitivity to a metabotropic glutamate 2/3 receptor agonist.
    Benneyworth MA; Smith RL; Sanders-Bush E
    Neuropsychopharmacology; 2008 Aug; 33(9):2206-16. PubMed ID: 17957214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening hallucinogenic drugs II. Systematic study of two behavioral tests.
    Calil HM
    Psychopharmacology (Berl); 1978 Jan; 56(1):87-92. PubMed ID: 415331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model.
    Canal CE; Morgan D
    Drug Test Anal; 2012; 4(7-8):556-76. PubMed ID: 22517680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The behavioral pharmacology of hallucinogens.
    Fantegrossi WE; Murnane KS; Reissig CJ
    Biochem Pharmacol; 2008 Jan; 75(1):17-33. PubMed ID: 17977517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonergic receptor subtypes and hallucinogen-induced stimulus control.
    Winter JC; Fiorella DJ; Timineri DM; Filipink RA; Helsley SE; Rabin RA
    Pharmacol Biochem Behav; 1999 Oct; 64(2):283-93. PubMed ID: 10515304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice.
    Benneyworth MA; Smith RL; Barrett RJ; Sanders-Bush E
    Psychopharmacology (Berl); 2005 Jun; 179(4):854-62. PubMed ID: 15645221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [BEHAVIORAL AND ELECTROGRAPHIC EFFECTS OF A HALLUCINOGEN IN THE UNRESTRAINED CAT].
    ROUGEUL A; VERDEAUX J; GOGAN P
    J Physiol (Paris); 1964; 56():435-6. PubMed ID: 14219852
    [No Abstract]   [Full Text] [Related]  

  • 10. A primate model for the study of hallucinogens.
    Schlemmer RF; Davis JM
    Pharmacol Biochem Behav; 1986 Feb; 24(2):381-92. PubMed ID: 3952128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plant hallucinogens: springboards for psychotherapeutic drug discovery.
    McKenna DJ
    Behav Brain Res; 1996; 73(1-2):109-16. PubMed ID: 8788486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug discrimination in behavioral toxicology.
    Colpaert FC
    Zentralbl Bakteriol Mikrobiol Hyg B Umwelthyg Krankenhaushyg Arbeitshyg Prav Med; 1987 Oct; 185(1-2):48-51. PubMed ID: 3124387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human drug discrimination: A primer and methodological review.
    Bolin BL; Alcorn JL; Reynolds AR; Lile JA; Rush CR
    Exp Clin Psychopharmacol; 2016 Aug; 24(4):214-28. PubMed ID: 27454673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvinorin A fails to substitute for the discriminative stimulus effects of LSD or ketamine in Sprague-Dawley rats.
    Killinger BA; Peet MM; Baker LE
    Pharmacol Biochem Behav; 2010 Sep; 96(3):260-5. PubMed ID: 20493209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulus properties of phenethylamine hallucinogens and lysergic acid diethylamide: the role of 5-hydroxytryptamine.
    Winter JC
    J Pharmacol Exp Ther; 1978 Feb; 204(2):416-23. PubMed ID: 621672
    [No Abstract]   [Full Text] [Related]  

  • 16. Behavior analysis and experimental pharmacology.
    Todorov JC
    Neurosci Biobehav Rev; 1981; 5(3):307-14. PubMed ID: 7029359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some observations on the behavioural effects of hallucinogenic drugs on rats: potentiation by two drugs affecting monoamine metabolism.
    Tonge SR; Leonard BE
    Arch Int Pharmacodyn Ther; 1972 Jan; 195(1):168-76. PubMed ID: 5010826
    [No Abstract]   [Full Text] [Related]  

  • 18. Arylalkylamine drugs of abuse: an overview of drug discrimination studies.
    Glennon RA
    Pharmacol Biochem Behav; 1999 Oct; 64(2):251-6. PubMed ID: 10515299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemistry and pharmacology of hallucinogens, entactogens and stimulants.
    Kovar KA
    Pharmacopsychiatry; 1998 Jul; 31 Suppl 2():69-72. PubMed ID: 9754836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminative stimulus properties of hallucinogens and related designer drugs.
    Glennon RA
    NIDA Res Monogr; 1991; (116):25-44. PubMed ID: 1369672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.